RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Stock-based compensation

AbbVie Inc.ABBV

Market cap
$417.4B
P/E ratio
SummaryFinancials
Period EndStock-based compensation (Million USD)YoY (%)
Dec 31, 2024911+21.95%
Dec 31, 2023747+11.33%
Dec 31, 2022671-3.03%
Dec 31, 2021692-8.10%
Dec 31, 2020753+75.12%
Dec 31, 2019430+2.14%
Dec 31, 2018421+15.34%
Dec 31, 2017365+3.40%
Dec 31, 2016353+25.18%
Dec 31, 2015282+17.01%
Dec 31, 2014241+13.68%
Dec 31, 2013212

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)